CD44 is the major adhesion molecule for the extracellular matrix components and is implicated in a wide variety of physiological and pathological processes including the regulation of tumor cell growth and metastasis. Our previous studies have shown that CD44 undergoes sequential proteolytic cleavages in the extracellular and transmembrane domains and the cleavage product derived from CD44 intramembranous cleavage acts as a signal transduction molecule. However, the underlying mechanism of the intramembranous cleavage of CD44 remains to be elucidated. In the present study, we report for the first time that CD44 is a substrate of the presenilin (PS)-dependent c-secretase. We demonstrate that the intramembranous cleavage of CD44 induced by 12-Otetradecanoylphorbol 13-acetate (TPA) treatment or mechanical scraping is blocked by c-secretase inhibitors in U251MG cells and that this cleavage is also inhibited in PS-deficient mouse embryonic fibroblasts. Furthermore, we showed that PS1 is redistributed to ruffling areas of the plasma membrane similarly to CD44 after TPA treatment, supporting our biochemical observation that PS1 is involved in the intramembranous cleavage of CD44. Our present findings suggest important implications for understanding CD44-dependent signal transduction and a potential role of PS/c-secretase activity in the functional regulation of adhesion molecules.
CD44 is the major adhesion molecule for the extracellular matrix components and is implicated in a wide variety of physiological and pathological processes including the regulation of tumor cell growth and metastasis. Our previous studies have shown that CD44 undergoes sequential proteolytic cleavages in the extracellular and transmembrane domains and the cleavage product derived from CD44 intramembranous cleavage acts as a signal transduction molecule. However, the underlying mechanism of the intramembranous cleavage of CD44 remains to be elucidated. In the present study, we report for the first time that CD44 is a substrate of the presenilin (PS)-dependent c-secretase. We demonstrate that the intramembranous cleavage of CD44 induced by 12-Otetradecanoylphorbol 13-acetate (TPA) treatment or mechanical scraping is blocked by c-secretase inhibitors in U251MG cells and that this cleavage is also inhibited in PS-deficient mouse embryonic fibroblasts. Furthermore, we showed that PS1 is redistributed to ruffling areas of the plasma membrane similarly to CD44 after TPA treatment, supporting our biochemical observation that PS1 is involved in the intramembranous cleavage of CD44. Our present findings suggest important implications for understanding CD44-dependent signal transduction and a potential role of PS/c-secretase activity in the functional regulation of adhesion molecules. Oncogene (2003 Oncogene ( ) 22, 1511 Oncogene ( -1516 Oncogene ( . doi:10.1038 Keywords: CD44; g-secretase; presenilin; intramembranous cleavage CD44, a type I membrane protein, is the major adhesion molecule for the extracellular matrix (ECM) components including hyaluronic acid (HA). It is expressed in most human cell types and is implicated in a wide variety of physiological and pathological processes, including lymphocyte homing and activation, wound healing, cell migration, and the regulation of tumor cell growth and metastasis (Aruffo et al., 1990; Culty et al., 1990; Gunthert et al., 1991; Lesley and Hyman, 1998; Weber et al., 2002) . The broad spectrum of functions suggests that CD44 can transduce multiple intracellular signals.
We previously proposed a proteolysis-model for the regulation of CD44 function ( Figure 1a ) (Okamoto et al., 1999a (Okamoto et al., , b, 2001 Kawano et al., 2000) . CD44 undergoes sequential proteolytic cleavages in the extracellular and transmembrane domains. The ectodomain cleavage is mediated by membrane-associated metalloproteases (MMPs) under the regulation of multiple signaling pathways such as the activation of PKC or the influx of calcium. The first cleavage process generates a soluble NH 2 -terminal fragment released into the culture supernatant (soluble CD44) and a membrane-bound COOH-terminal cleavage product (CD44EXT, CD44 extracellular truncation). This cleavage is responsible for dynamic regulation of the interaction between CD44 and the extracellular matrix during cell migration. Following the ectodomain cleavage, the intramembranous cleavage of CD44EXT occurs, resulting in the release of a CD44 intracellular domain (CD44ICD) into cytoplasm. Furthermore, we demonstrated that CD44ICD translocates into nucleus and enhances transcription that is mediated through the TPA-responsive element. Therefore, the sequential proteolytic cleavage is crucial for CD44-mediated signaling pathway. However, the precise molecular mechanism of the intramembranous cleavage of CD44 remains to be resolved.
We have previously shown that treatment of human glioma U251MG cells with 12-O-tetradecanoylphorbol 13-acetate (TPA) induces the ectodomain cleavage of CD44 and further incubation of cells in fresh medium induces the intramembranous cleavage of CD44 (Okamoto et al., 2001) . These cleavage fragments are detectable by immunoblot analysis with antibodies raised to the COOH-terminal region of the protein (antiCD44cyto Ab) ( Figure 1b, lanes 2 and 3) . These sequential cleavages are blocked by BB94, a specific metalloprotease inhibitor (Figure 1b, lane 4) . To explore the mechanism of CD44 intramembranous cleavage, we tested the effect of protease inhibitors on the intramembranous cleavage of CD44. We previously demonstrated the prevention of the CD44 intramembranous cleavage under the presence of MG132, an intracellular broadspectrum protease inhibitor (Figure 1b , lane 5) (Okamoto et al., 2001) . In the present study, we found that CD44 intramembranous cleavage was also blocked by (5 mm) (lane 4) and then treated with TPA (100 ng/ml) for 30 min (lanes 2-6). After TPA treatment, cells were washed and incubated for additional 6 h with fresh medium in the absence (lanes 3 and 4) or presence of carbobenzoxy-l-leucyl-l-leucyl-l-leucinal (MG132) (15 mm) (lane 5) or pepstatin A (300 mm) (lane 6). Cells were directly lysed in Laemmli buffer. Equal amounts of cell lysates were separated by SDS-PAGE, transferred onto nitrocellulose filters and detected as previously described (Okamoto et al., 2001) . Blots were probed with the rabbit polyclonal antibodies against the cytoplasmic region of CD44 (anti-CD44cyto Ab), and visualized by enhanced chemiluminescence detection (Amersham Pharmacia Biotech). (c) Cells were left untreated (lanes 1 and 7) or incubated with TPA for 30 min (lanes 2-6 and 8-12). After TPA treatment, cells were washed and incubated in the absence (lanes 2 and 8) or presence of L-685,458 (lanes 3-6), DAPT (lanes 9 and 10), or compound E (lanes 11 and 12) at the indicated concentration. Immunoblot analysis was performed as described above. Blots were proved with anti-CD44cyto Ab or the rabbit polyclonal antibodies C4 against the cytoplasmic C-terminus of human bAPP. (d) Cells were left untreated (lane 1) or mechanically scraped in the absence (lanes 2 and 3) or presence of BB94 (5 mm) (lane 4), L-685,458 (lanes 5 and 6), DAPT (lanes 7 and 8) or compound E (lanes 9 and 10) at the indicated concentration. Cells were collected immediately after scraping (lane 2) or after incubation for additional 4 h in suspension (lanes 3-10). The cell pellets were lysed in Laemmli buffer and subjected to immunoblot analysis using anti-CD44cyto Ab as described above. TPA, MG132, and pepstatin A were obtained from Sigma Chemical Co., Inc. L-685,458 was purchased from BACHEM AG Presenilin-dependent c-secretase activity D Murakami et al the treatment with pepstatin A, a classical inhibitor of aspartyl class proteases (Figure 1b , lane 6). Both MG132 and pepstatin A have been reported to inhibit the intramembranous cleavage of the amyloid precursor protein (APP) and Notch (Evin et al., 1995; De Strooper et al., 1999) that is mediated by g-secretase activity (Esler and Wolfe, 2001; De Strooper and Annaert, 2001 ). Based on these findings, we hypothesized that gsecretase activity is involved in the intramembranous cleavage of CD44. g-Secretase cleavage is a novel type of proteolytic processing of type I membrane proteins, occurring in the hydrophobic environment of the cell membrane (De Strooper and Annaert, 2001) . To examine the involvement of g-secretase activity in CD44 intramembranous processing, we first utilized L-685,458, a specific inhibitor of g-secretase (Shearman et al., 2000) . This compound inhibited the production of CD44ICD in a concentration-dependent manner, leading to the accumulation of CD44EXT (Figure 1c, lanes 3-6) . The COOH-terminal stubs of APP, which are known substrates of g-secretase, accumulated in the presence of L-685,458 in a similar manner to CD44EXT (Figure 1c ). Furthermore, we tested other g-secretase inhibitors, DAPT (May et al., 2002) and compound E (Seiffert et al., 2000) . The presence of these inhibitors also blocked the production of CD44ICD in a concentration-dependent manner, resulting in the accumulation of CD44EXT (Figure 1c, lanes 9-12) .
We have shown previously that mechanical scraping of U251MG cells, which mimics cell wounding in vivo and induces the transient influx of calcium, promotes the sequential cleavage of CD44 and a metalloprotease inhibitor blocks this cleavage (Figure 1d, lanes 2-4) 
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Presenilin-dependent c-secretase activity D Murakami et al (Okamoto et al., 2001) . We thus examined the effect of g-secretase inhibitors on the intramembranous cleavage of CD44 in this physiological process. All three g-secretase inhibitors suppressed the intramembranous cleavage of CD44 induced by mechanical scraping (Figure 1d, lanes 5-10) . Taken together, g-secretase activity appears to be involved in the intramembranous cleavage of CD44 under the physiological condition.
The polytopic membrane proteins presenilins (PSs), presenilin-1 (PS1) and presenilin-2 (PS2), which were first identified because of their association with familial Alzheimer's disease (FAD) (Levy-Lahad et al., 1995; Rogaev et al., 1995; Sherrington et al., 1995) , are major constituents of the g-secretase-mediated transmembrane cleavage (De Strooper and Annaert, 2001; Esler and Wolfe, 2001) . We therefore investigated the involvement of PSs in the g-secretase-mediated CD44 intramembranous cleavage. For this purpose, we employed PSdeficient mouse embryonic fibroblasts (MEFs). A cDNA encoding full-length human CD44 was transfected into wild-type and PS-deficient (PS1À/À, PS2À/À, and PS1/PS2 double-knockout) MEFs (Herreman et al., 2000) . Immunoblots of the lysates of wildtype MEFs transfected with full-length CD44 revealed the fragments of CD44EXT and CD44ICD in addition to the overexpressed full-length CD44 fragment ( Figure 2a, lane 2) . Treatment with L-685,458 blocked the intramembranous cleavage of CD44 (Figure 2a , lane 3), revealing that CD44ICD is generated by g-secretasemediated proteolytic machinery in transfected MEFs as well. The CD44ICD proteolytic fragment was also found in PS2À/À cells transfected with full-length CD44 (Figure 2b, lane 6) . In contrast, CD44ICD fragment was hardly detectable in PS1À/À cells (Figure 2b, lane 4) and double-knockout cells (Figure 2b, lane 8) . These results indicate a direct role for presenilin, especially PS1, in the intramembranous cleavage of CD44. The production of CD44ICD in PS2À/À cells is probably because the endogenously expressed PS1 in MEFs could compensate for the ablation of PS2 function as previously observed in PS2À/À mice (Herreman et al., 1999) .
To determine whether PS interacts with CD44 intracellularly, we next investigated the subcellular localization of CD44 and PS1 in U251MG cells. Confocal microscopic analysis of cells without any treatment showed that CD44 was mainly localized to filopodia of the plasma membrane (Figure 3a) . PS1 was abundant in the perinuclear region (Figure 3b ) as previously reported (De Strooper et al., 1997) . However, a small amount of PS1 was detected at the plasma membrane ( Figure 3b ) and colocalized with CD44 partially (Figure 3c ). This observation is consistent with finding in a recent report that a fraction of PS1 is localized to the plasma membrane in certain cell types (Kaether et al., 2002) . Treatment of cells with TPA induced membrane ruffling over the entire cell surface and CD44 was redistributed to the TPA-induced ruffling areas (Figure 3d) . Notably, TPA treatment also induced the redistribution of PS1 to these ruffling areas (Figure 3e ) where colocalization of CD44 and PS1 was observed (Figure 3f ). The same results were obtained when single staining of PS1 was performed (data not shown). Our result that PS1 was redistributed to the ruffling areas with CD44 after TPA treatment suggests the role of PS1 in the intramembranous cleavage of CD44.
In this report, we demonstrate for the first time that CD44 represents a novel substrate that undergoes PSdependent g-secretase proteolysis. Recent evidence shows that ErbB-4, E-cadherin, and LRP, in addition (Okamoto et al., 2001 ) was transiently transfected into wild-type MEFs using LipofectAMINE and PLUS Reagent (Life Technologies, Inc.) according to the manufacturer's instruction. At 24 h after transfection, cells were incubated in the presence (lane 3) or absence (lanes 1, 2) of L685,458 (100 nm) for additional 24 h. Butyric acid (Sigma) was added at a final concentration of 10 mm to increase protein expression levels. Immunoblot analysis was performed with anti-CD44cyto Ab. (b) A cDNA encoding full-length CD44 or empty vector was transiently transfected into wild-type (lanes 1 and 2), PS1À/À (lanes 3 and 4), PS2À/À (lanes 5 and 6), and PS1/PS2 double-knockout (lanes 7 and 8) MEFs. Cells are incubated in the presence of butyric acid, lysed and subjected to immunoblot analysis Presenilin-dependent c-secretase activity D Murakami et al to APP and Notch, are substrates for PS/g-secretase cleavage (Ni et al., 2001; Lee et al., 2002; Marambaud et al., 2002; May et al., 2002) . With exception of Notch, the detail biological outcome following these intramembranous cleavages remains to be elucidated. However, it appears that these membrane proteins are directly involved in intracellular signal transduction pathways by this cleavage mechanism (Cao and Sudhof, 2001; Ni et al., 2001; Baek et al., 2002) . We have recently demonstrated that CD44ICD, cleavage products derived from CD44 intramembranous cleavage, acts as a signal transduction molecule, where it participates in gene transcription (Okamoto et al., 2001) . In this regard, our present findings have important implications for understanding how CD44 transduces a signal into cells. It has been reported that removal of the ectodomain is generally required before PS/g-secretase cleavage in the transmembrane region takes place. In accordance with this rule, we have previously shown the requirement of metalloprotease-mediated ectodomain cleavage of CD44 for the subsequent intramembranous cleavage (Okamoto et al., 2001) . The proteolytic cleavage of CD44 at each domain regulates CD44-mediated cell behavior with relevance for cancer biology. We and other groups have also shown that the E-cadherin ectodomain is cleaved by metalloproteases (Ito et al., 1999; Noe et al., 2001) , and the resultant products can serve as substrates for presenilin-dependent transmembrane cleavage (Marambaud et al., 2002) . PS/g-secretase cleavage of E-cadherin has been found to induce disassembly of cadherin-based adherens junctions and abrogation of cadherin-mediated cell-cell adhesion (Marambaud et al., 2002) . Furthermore, the potential importance of intracellular fragment of cadherin in signal transduction is indicated in recent studies (Sadot et al., 1998) . Thus, accumulating evidence suggests that PS/g-secretase cleavage of adhesion molecules is a key mechanism for their functional regulation. Of note, one determination of whether a protein is a substrate for presenilin-dependent cleavage appears to be the size of extracellular domain rather than the recognition of specific target sequences (Struhl and Adachi, 2000) . Since several other adhesion molecules, similarly to CD44 and E-cadherin, are found to be cleaved at the ectodomain (Hooper et al., 1997; Egeblad and Werb, 2002) , they may be also targeted for PS/g-secretase intramembranous cleavage. Further investigation of proteolytic cleavages of adhesion molecules will provide Figure 3 Localization of PS1 at cell surface and redistribution of CD44 and PS1 to TPA-induced membrane ruffling. U251MG cells grown on 35-mm culture dishes were left untreated (a-c) or treated with TPA for 10 min (d-f). Cells were fixed with 4% paraformaldehyde for 15 min followed by 0.2% Triton X-100 in PBS for 5 min and were blocked with PBS containing 3% bovine serum albumin for 60 min at room temperature. The cells were incubated in the mouse monoclonal antibody BU52 against the ectodomain epitope of CD44 (Ancell, Bayport, MN, USA) and the goat polyclonal antibodies N-19 against the N-termimus of human PS1 (Santa Cruz Biotechnology, Inc.) diluted in PBS containing 0.2% bovine serum albumin overnight at room temperature, washed three times in PBS, and then incubated for 60 min at room temperature with the appropriate secondary antibodies linked to fluorescein isothiocyanate and Cy3 diluted in PBS. After being washed with PBS, samples were mounted in 80% glycerol and visualized with a confocal microscope (Fluoview, Olympus, Tokyo, Japan). The merged pictures of the left two panels are shown in the right panel. Bar, 20 mm Presenilin-dependent c-secretase activity D Murakami et al new insights into their functional role in diverse biological processes.
Note added in proof After this paper was submitted, similar observations were reported by Lammich et al., 2002 (J. Biol. Chem., 277, 44754-44759) . They mainly examined the PS/g-secretase cleavage of CD44 in culture cells transfected with cDNA encoding CD44DE, which mimics the product of the ectodomainshedded CD44. In our present study, we demonstrated the PS/g-secretase cleavage of not only overexpressed full-length CD44 but also endogenous CD44 under the physiological condition.
